Our law firm is investigating claims against Johnson & Johnson for the manufacturing and sale of the anti-psychotic medication Risperdal. According to FDA warnings and several studies conducted by scientific research institutions the use or Risperdal (Risperdone) may result in gynecomastia in males.
A frequently asked and important question asked by clients who contact our law firm regarding the filing of a lawsuit against manufacturers of Risperdal is, “what is the value of my case”, or “how much is my case worth.”
The value of a drug side effect case is dependent on several interrelated factors including the severity of the injury suffered, and the level of emotional trauma sustained because of the development of dangerous medical complications due to the use of the medication. Visit this page for more infomration on Risperdal class action lawsuits
Legal Help Second Opinion from Our Attorneys
If you have an active risperdal lawsuit claim and wold like a second opinion from one of our attorneys feel free to contact our office. We can provide you with a detailed re-assesement of your case and provide you with information regarding the potential value of your claim. All second opinions are provide absolutely free of charge. Every case is different encompassing a unique set of factors which determine the overall value of your case. The best way to determine the estimated value of a case is by way of a legal consultation with an experienced risperdal attorney. Our law firm is proud to provide all potential clients with a free case evaluations where the estimated value of your case can be assessed. To reach out to us feel free to contact our law offices toll free (855)385-2529. Note: All consultations are free of charge and confidential.
Factors in Determining the Value of a Risperdal Lawsuit:
1. The severity and magnitude of the harm suffered: Individuals who have suffered breast tissue growth may have to sustain tens of thousands of dollars in medical expenses including reconstructive surgeries, doctor consultations, new medications and rehabilitation care. Such victims are entitled to compensation for all medical and health related expenses arising out of the use of the defective medication.
2. Level of pain and suffering associated with the harm: Emotional harm is a main component in determining the estimated value of any personal injury lawsuit. Individuals have a right to receive compensation for the physical harm and psychological suffering resulting from the negligent or intentional acts of other.
3. Whether you join a class action lawsuit or decide to file a single party claim: Class action claims bring together individual victims who have a common issue of fact or law against one liable party. Settlements in class action lawsuit are awarded on a proportional basis and not based on the severity or magnitude of the harm suffered. For example if there are 100 member in a class action lawsuit and the settlement for the class is $100 million dollars each plaintiff will receive the same amount of money despite the fact that some individuals may have injuries more severe than the rest of the class. It may be more beneficial for individuals who have relatively severe injuries to opt out of a class action lawsuit and instead file a single party claim.
4. Availability of punitive damages: Punitive damages are awarded when a negligent party acts with wanton or reckless disregard for the life and health of consumers. In many instance pharmaceutical giants fail to properly warn users of their medications of the dangerous side effects which may result from their use.
Free Second Opinion and Case Review
Unfortunately the majority of personal injury and defective drug law firms are not able to fully assess the potential value of a risperdal gynecomstia claim. Our experienced attorneys are able to provide victims of defective prescription medications including risperdal with free no sots case evaluations where we can determine the potential value of you claims. To speak with an attorney contact our law offices toll free 855-385-2529.